PAPER
SEARCH RESULTS
331254 RESULTS
PAPER Vermeiren Y, Van Dam D, Aerts T, Engelborghs S, De Deyn PP
Brain region-specific monoaminergic correlates of neuropsychiatric symptoms in Alzheimer's disease.
J Alzheimers Dis. 2014;41(3):819-33. PubMed: 24685637PAPER Wilhelmus MM, de Jager M, Bakker EN, Drukarch B
Tissue transglutaminase in Alzheimer's disease: involvement in pathogenesis and its potential as a therapeutic target.
J Alzheimers Dis. 2014 Jan 1;42:S289-303. PubMed: 24685636PAPER Sun Q, Hampel H, Blennow K, Lista S, Levey A, Tang B, Li R, Shen Y
Increased plasma TACE activity in subjects with mild cognitive impairment and patients with Alzheimer's disease.
J Alzheimers Dis. 2014;41(3):877-86. PubMed: 24685635PAPER Shih YH, Tsai KJ, Lee CW, Shiesh SC, Chen WT, Pai MC, Kuo YM
Apolipoprotein C-III is an amyloid-β-binding protein and an early marker for Alzheimer's disease.
J Alzheimers Dis. 2014;41(3):855-65. PubMed: 24685634PAPER Cadena-del-Castillo C, Valdes-Quezada C, Carmona-Aldana F, Arias C, Bermúdez-Rattoni F, Recillas-Targa F
Age-dependent increment of hydroxymethylation in the brain cortex in the triple-transgenic mouse model of Alzheimer's disease.
J Alzheimers Dis. 2014;41(3):845-54. PubMed: 24685633PAPER Alegret M, Cuberas-Borrós G, Espinosa A, Valero S, Hernández I, Ruíz A, Becker JT, Rosende-Roca M, Mauleón A, Sotolongo O, Castell-Conesa J, Roca I, Tárraga L, Boada M
Cognitive, genetic, and brain perfusion factors associated with four year incidence of Alzheimer's disease from mild cognitive impairment.
J Alzheimers Dis. 2014;41(3):739-48. PubMed: 24685632PAPER Engvig A, Fjell AM, Westlye LT, Skaane NV, Dale AM, Holland D, Due-Tønnessen P, Sundseth O, Walhovd KB
Effects of cognitive training on gray matter volumes in memory clinic patients with subjective memory impairment.
J Alzheimers Dis. 2014;41(3):779-91. PubMed: 24685630PAPER Zlatar ZZ, Wierenga CE, Bangen KJ, Liu TT, Jak AJ
Increased hippocampal blood flow in sedentary older adults at genetic risk for Alzheimer's disease.
J Alzheimers Dis. 2014;41(3):809-17. PubMed: 24685629PAPER Shea TB, Rogers E
Has prenatal folate supplementation established an at-risk population for age-related cognitive decline?
J Alzheimers Dis. 2014;41(3):667-9. PubMed: 24685628PAPER Tsivgoulis G, Katsanos AH, Papageorgiou SG, Dardiotis E, Voumvourakis K, Giannopoulos S
The role of neurosonology in the diagnosis of vascular dementia.
J Alzheimers Dis. 2014 Jan 1;42:S251-7. PubMed: 24685627PAPER Lee GJ, Lu PH, Mather MJ, Shapira J, Jimenez E, Leow AD, Thompson PM, Mendez MF
Neuroanatomical correlates of emotional blunting in behavioral variant frontotemporal dementia and early-onset Alzheimer's disease.
J Alzheimers Dis. 2014;41(3):793-800. PubMed: 24685626PAPER Zhao Y, Zhao H, Lobo N, Guo X, Gentleman SM, Ma D
Celastrol enhances cell viability and inhibits amyloid-β production induced by lipopolysaccharide in vitro.
J Alzheimers Dis. 2014;41(3):835-44. PubMed: 24685625PAPER Marshall GA, Lorius N, Locascio JJ, Hyman BT, Rentz DM, Johnson KA, Sperling RA
Regional cortical thinning and cerebrospinal biomarkers predict worsening daily functioning across the Alzheimer's disease spectrum.
J Alzheimers Dis. 2014;41(3):719-28. PubMed: 24685624PAPER Chung SJ, Kim MJ, Kim J, Kim YJ, You S, Koh J, Kim SY, Lee JH
Exome array study did not identify novel variants in Alzheimer's disease.
Neurobiol Aging. 2014 Aug;35(8):1958.e13-4. Epub 2014 Mar 11 PubMed: 24685331Current Filters
No filters selected